Clinical Trial Update: Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fexofenadine for seasonal allergic rhinitis in the presence of pollutants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fexofenadine (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis Seasonal | Phase 3 | Status: COMPLETED